Literature DB >> 24613160

Graft patency after off-pump coronary artery bypass surgery is inferior even with identical heparinization protocols: results from the Danish On-pump Versus Off-pump Randomization Study (DOORS).

Kim Houlind1, Morten Fenger-Grøn2, Susanne J Holme3, Bo J Kjeldsen4, Susanne N Madsen5, Bodil S Rasmussen6, Mogens H Jepsen7, Jan Ravkilde8, Jens Aaroe9, Peter Riis Hansen10, Henrik Steen Hansen11, Poul Erik Mortensen4.   

Abstract

OBJECTIVE: To determine whether graft patency after on-pump and off-pump coronary artery bypass surgery is similar when performed using the same heparinization protocol.
METHODS: In a randomized, controlled, multicenter trial, 900 patients more than 70 years of age received either on-pump or off-pump coronary artery bypass surgery. Heparin was given to achieve an activated clotting time of 400 seconds before arteriotomy in both groups. After the procedure, protamine sulfate was given to revert the activated clotting time to less than 120 seconds. Coronary angiography was performed 6 months after the operation and graft patency was assessed by independent blinded observers.
RESULTS: A total of 481 patients underwent angiography. In the off-pump group, 561 (79%) of 710 grafts were open, 65 (9%) were stenotic, and 84 (12%) were occluded. In the on-pump group, 549 (86%) of 650 grafts were open, 38 (5%) were stenotic, and 63 (9%) were occluded. The difference between the proportion of open grafts was statistically significant in favor of on-pump surgery (P=.01). The proportion of open left internal thoracic artery grafts was 95% in both groups. Perioperative use of intracoronary shunts did not increase the risk of stenosis of the coronary artery distal to the anastomosis.
CONCLUSIONS: Despite comparable heparinization, graft patency after off-pump surgery was inferior to that after on-pump surgery.
Copyright © 2014 The American Association for Thoracic Surgery. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24613160     DOI: 10.1016/j.jtcvs.2014.02.024

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  8 in total

1.  Anaortic total arterial OPCAB - Panacea to all ills?

Authors:  O P Yadava
Journal:  Indian Heart J       Date:  2015-06-13

2.  Comparison of Mid-Term Graft Patency between On-Pump and Off-Pump Coronary Artery Bypass Grafting.

Authors:  Tatsuya Seki; Toshihito Yoshida
Journal:  Ann Thorac Cardiovasc Surg       Date:  2017-04-19       Impact factor: 1.520

Review 3.  Current outcomes of off-pump coronary artery bypass grafting: evidence from real world practice.

Authors:  Piroze M Davierwala
Journal:  J Thorac Dis       Date:  2016-11       Impact factor: 2.895

Review 4.  Off-Pump Coronary Artery Bypass Grafting; is it Still Relevant?

Authors:  Chima K P Ofoegbu; Rodgers M Manganyi
Journal:  Curr Cardiol Rev       Date:  2022

Review 5.  Off-pump coronary artery bypass grafting in octogenarians.

Authors:  Shahzad G Raja
Journal:  J Thorac Dis       Date:  2016-11       Impact factor: 2.895

Review 6.  Current Status of Off-Pump Coronary Artery Bypass.

Authors:  Go Kuwahara; Tadashi Tashiro
Journal:  Ann Thorac Cardiovasc Surg       Date:  2020-05-29       Impact factor: 1.520

7.  Early and long-term outcomes of coronary artery bypass surgery with and without use of heart-lung machine and with special respect to renal function - A retrospective study.

Authors:  Julia Merkle; Jaison Sunny; Laura Ehlscheid; Anton Sabashnikov; Carolyn Weber; Kaveh Eghbalzadeh; Ilija Djordjevic; Oliver Liakopoulos; Yeong-Hoon Choi; Thorsten Wahlers; Mohamed Zeriouh
Journal:  PLoS One       Date:  2019-10-10       Impact factor: 3.240

Review 8.  Current randomized control trials, observational studies and meta analysis in off-pump coronary surgery.

Authors:  Haralabos Parissis; Man Chi Lau; Mondrian Parissis; Savvas Lampridis; Victoria Graham; Reza Al-Saudi; Peter Mhandu
Journal:  J Cardiothorac Surg       Date:  2015-12-17       Impact factor: 1.637

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.